2 hrs ago
FDA approves test to detect DNA of cancer-causing HPV strains
The Food and Drug Administration on Thursday approved the use of a test for cancer-causing strains of the human papillomavirus , clearing the way for replacement of the Pap smears used to screen most women for cervical cancer.
Trending on the Topix Network
11 hrs ago
Going out on top, Facebook CFO moves on
The world's largest social media network reported record first quarter results late Wednesday and CFO David Ebersman used the occasion to announce his departure.
Tue Apr 22, 2014
Novartis Cancer Move Adds Spice to Rivalry with Roche
Sitting just two miles apart on opposite banks of the Rhine river in Basel , Switzerland , Novartis AG and Roche Holding AG have long had a complex crosstown rivalry.
The Tweedy Browne Global Value Fund's Top First Quarter Holdings
The Tweedy Browne Global Value Fund seeks long-term growth of capital by investing throughout the world in a diversified portfolio consisting primarily of non-U.S. marketable equity securities.
Mon Apr 21, 2014
UCSF geneticist joins Google's Calico project
Google has offered few details about Calico, one of its "moon shot" projects, other than to say the effort is to fight age-related diseases.
Fri Apr 18, 2014
Best Places to Work 2014
Genentech is number 1 in the largest Best Places to Work, with 9500 employees and headquarters in South San Francisco.
Wed Apr 16, 2014
Iconic Therapeutics snags $20 million, eyes challenge to Genentech
New Iconic Therapeutics CEO William Greene was involved in the early clinical development of Lucentis, an FDA-approved therapy for wet AMD, while at Genentech.
Tue Apr 15, 2014
Eye-disease drug is lucrative for Genentech, doctors
Some of the nation's most highly reimbursed doctors receive millions of dollars of Medicare payments a year from just one drug made by Genentech.
Wall Street Journal
Roche Sales Hurt by Strong Franc
Swiss drug maker Roche Holding AG reported a 1% dip in first-quarter revenue as the strong Swiss franc eroded the value of growing sales of its cancer drugs.
Mon Apr 14, 2014
Another two bite the dust - Hospira v Genentech
The IPKat has just been perusing the meaty yet compact decision in the case of Hospira v Genentech ) which came out last Thursday from Mr Justice Birss.
Sat Apr 12, 2014
Thunder and wonder combine for a blast at Kentucky Science Center
The event is held in conjunction with the Kentucky Derby Festival's Thunder Over Louisville opening ceremonies since the Science Center has great views of the Ohio River where the fireworks and air show are held.
Thu Apr 10, 2014
The Washington Post
Hospira Wins U.K. Court Challenge to Roche Cancer-Drug Patents
Hospira Inc.'s U.K. unit won a court ruling overturning two patents for Roche Holding AG's top- selling breast-cancer drug Herceptin, paving the way for the generic drug-maker to sell a cheaper competitor in the country.
Wed Apr 09, 2014
New Molecular Pharmaceuticals Findings from Genentech, Inc. Described
The Taconic Hepatic CYP Reductase Null mouse model possesses a targeted mutation that results in liver-specific deletion of the Por gene thereby resulting in a disruption of CYP metabolism in the liver."
Flu Drugs May Do More Harm Than Good, Researchers Find
Tamiflu and Relenza, antiviral drugs stockpiled by governments to tame influenza outbreaks, haven't been proven to prevent pandemics and may cause more harm in some patients than good, researchers said after reviewing 170,000 pages of clinical-trial data.
Mon Apr 07, 2014
More data, better drugs: Genentech, PatientsLikeMe ink groundbreaking research pact
Genentech Inc. will mine the deep online patient network of PatientsLikeMe to pinpoint ways of using patients' real experience with diseases and drugs for better research.
Roche Will Work With Oryzon on Cancer-Suppressing Genes
Roche Holding AG will buy the rights to a drug meant to switch on genes that block cancer's growth in a deal to be announced today with Oryzon Genomics SA .
Thu Apr 03, 2014
Webcor Signs On For FLEXLAB's First Private-Sector Project
Buildings do not always perform as expected, says Stephen E. Selkowitz, senior adviser for building science at the Lawrence Berkeley National Laboratory.
Tue Apr 01, 2014
Firestone Ventures (TSX.V:FV; FSE:F5V) Announces Management Changes
Firestone Ventures Inc. is pleased to announce the appointments of Mr. F. Carson Noel, LL.B., MBA, as President & CEO as well as Director of the Company, and Ms.
Mon Mar 31, 2014
The Motley Fool
FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge
Now the Lexington, Mass.-based company will have to make something of it. Curis said today that the FDA has lifted the partial clinical hold on CUDC-427 , the experimental cancer drug it licensed from Genentech a few years ago.
UPDATE 1-FDA allows Curis to resume testing cancer drug
Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing of its experimental cancer drug, lifting a November order halting enrolment in an early-stage trial.